Who are Prevantics Maxi Swabstick's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): A (Chloraprep), Chlorhexidine-Alcohol, CHG 2% w/v and IPA 70% v/v, Iodine povidone, Iodophor (10% povidone-iodine), Povidone-iodine irrigation.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/prevantics-maxi-swabstick.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Prevantics Maxi Swabstick — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevantics Maxi Swabstick (Prevantics Maxi Swabstick) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antiseptic. Area: Infection Prevention.

marketed Topical antiseptic Infection Prevention Small molecule Live · refreshed every 30 min

Target snapshot

Prevantics Maxi Swabstick (Prevantics Maxi Swabstick) — Professional Disposables International, Inc.. Prevantics Maxi Swabstick is a topical antiseptic swab that disinfects skin prior to medical procedures using chlorhexidine gluconate and isopropyl alcohol.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Prevantics Maxi Swabstick TARGET	Prevantics Maxi Swabstick	Professional Disposables International, Inc.	marketed	Topical antiseptic
A (Chloraprep)	A (Chloraprep)	Instituto de Investigacion Sanitaria La Fe	marketed	Topical antiseptic	Bacterial cell membrane and proteins
Chlorhexidine-Alcohol	Chlorhexidine-Alcohol	Poitiers University Hospital	marketed	Topical antiseptic
CHG 2% w/v and IPA 70% v/v	CHG 2% w/v and IPA 70% v/v	Johns Hopkins University	marketed	Topical antiseptic/antimicrobial combination
Iodine povidone	Iodine povidone	Montefiore Medical Center	marketed	Topical antiseptic/disinfectant
Iodophor (10% povidone-iodine)	Iodophor (10% povidone-iodine)	University of California, Irvine	marketed	Topical antiseptic/disinfectant
Povidone-iodine irrigation	Povidone-iodine irrigation	Corewell Health East	marketed	Topical antiseptic/disinfectant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antiseptic class)

Poitiers University Hospital · 2 drugs in this class
Professional Disposables International, Inc. · 2 drugs in this class
Central DuPage Hospital · 2 drugs in this class
Solventum US LLC · 1 drug in this class
University of British Columbia · 1 drug in this class
University of Iowa · 1 drug in this class
C. R. Bard · 1 drug in this class
Zurex Pharma, Inc. · 1 drug in this class
Instituto de Investigacion Sanitaria La Fe · 1 drug in this class
Johnson & Johnson Consumer Inc. (J&JCI) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prevantics Maxi Swabstick — Competitive Intelligence Brief. https://druglandscape.com/ci/prevantics-maxi-swabstick. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab